MM1-type sporadic Creutzfeldt-Jakob disease with 1-month total disease duration and early pathologic indicators
- PMID: 28402042
- DOI: 10.1111/neup.12379
MM1-type sporadic Creutzfeldt-Jakob disease with 1-month total disease duration and early pathologic indicators
Abstract
A 62-year-old man presented with abnormal behavior and cognitive impairment. Diffusion-weighted images (DWI) obtained on MRI showed extensive hyperintense regions in the cerebral cortex and striatum. Myoclonus was recognized, and the patient died 1 month after the onset; his condition did not reach the akinetic mutism state. The brain weighed 1300 g and showed no apparent atrophy. Extensive spongiform changes were observed in the cerebral neocortex, striatum, thalamus and cerebellar cortex, but gliosis was mild or absent. Neuropil rarefaction and neuron loss were not apparent. Mild proliferation of anti- GFAP-positive astrocytes was observed in the cerebral cortex, but unaffected regions were noted. Regions without spongiform changes and GFAP-positive astrocytes included the hippocampal formation and subiculum. PrP immunostaining showed extensive diffuse synaptic-type PrP deposition in the gray matter, including the hippocampal region, but it was also mild. PrP gene analysis revealed no mutation with methionine homozygosity at polymorphic codon 129. Western blot analysis of proteinase K-resistant PrP indicated type 1 PrPSc . The clinicopathological findings of the present case confirm several hypotheses: (i) the earliest pathologic evidence observed by HE staining in CJD are spongiform changes; (ii) DWI hyperintense regions indicate these spongiform changes; and (iii) regions without spongiform changes, gliosis and proliferation of GFAP-positive astrocytes, but with PrP deposition, exist in the early disease stage.
Keywords: Creutzfeldt-Jakob disease; diffusion-weighted MRI; preclinical stage; prion protein deposition; spongiform change.
© 2017 Japanese Society of Neuropathology.
Similar articles
-
An autopsied case of MM1 + MM2-cortical with thalamic-type sporadic Creutzfeldt-Jakob disease presenting with hyperintensities on diffusion-weighted MRI before clinical onset.Neuropathology. 2017 Feb;37(1):78-85. doi: 10.1111/neup.12327. Epub 2016 Jul 20. Neuropathology. 2017. PMID: 27436355
-
Creutzfeldt-Jakob disease.Neuropathology. 2017 Apr;37(2):174-188. doi: 10.1111/neup.12355. Epub 2016 Dec 28. Neuropathology. 2017. PMID: 28028861 Review.
-
An autopsied case of Creutzfeldt-Jakob disease with mutation in the prion protein gene codon 232 and type 1+2 prion protein.Neuropathology. 2013 Oct;33(5):568-75. doi: 10.1111/neup.12013. Epub 2013 Jan 16. Neuropathology. 2013. PMID: 23320809
-
Autopsied case of sporadic Creutzfeldt-Jakob disease classified as MM1+2C-type.Neuropathology. 2019 Jun;39(3):240-247. doi: 10.1111/neup.12557. Epub 2019 May 7. Neuropathology. 2019. PMID: 31062411
-
[Clinicopathological characteristics of Creutzfeldt-Jakob disease with a PrP V180I mutation and M129V polymorphism on different alleles].Rinsho Shinkeigaku. 1999 Aug;39(8):800-6. Rinsho Shinkeigaku. 1999. PMID: 10586622 Review. Japanese.
Cited by
-
Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.J Clin Invest. 2020 Mar 2;130(3):1350-1362. doi: 10.1172/JCI131564. J Clin Invest. 2020. PMID: 31985492 Free PMC article.
-
Prion protein post-translational modifications modulate heparan sulfate binding and limit aggregate size in prion disease.Neurobiol Dis. 2020 Aug;142:104955. doi: 10.1016/j.nbd.2020.104955. Epub 2020 May 24. Neurobiol Dis. 2020. PMID: 32454127 Free PMC article.
-
System degeneration in an MM1-type sporadic Creutzfeldt-Jakob disease case with an unusually prolonged akinetic mutism state.Prion. 2021 Dec;15(1):12-20. doi: 10.1080/19336896.2020.1868931. Prion. 2021. PMID: 33472525 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous